Insulin Secretagogue Market Size, Scope, Research report to 2035
The Global Insulin Secretagogue Industry focuses on the medications (sulfonylureas, glinides, DPP-4 inhibitors) that stimulate the pancreas to produce more insulin for type 2 diabetes management. The rising diabetes prevalence and demand for affordable oral therapies are driving the industry growth. An insulin secretagogue defined as substance stimulating the secretion of insulin from the pancreas, contributing to the regulation of blood glucose levels.